Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Michael Lincoff

Showing results (241-250 of 353) with videos related to

Pageof 36
Sort By:
Circulation|December 23, 2009
Prognostic modeling of individual patient risk and mortality impact of ischemic and hemorrhagic complications: assessment from the Acute Catheterization and Urgent Intervention Triage Strategy trialStuart J Pocock, Roxana Mehran, Tim C Clayton, et al.
Journal of the American College of Cardiology|May 23, 2009
Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trialRamin Ebrahimi, Cornelius Dyke, Roxana Mehran, et al.
JACC. Cardiovascular Interventions|May 26, 2009
Influence of timing of clopidogrel treatment on the efficacy and safety of bivalirudin in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention: an analysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trialA Michael Lincoff, Steven R Steinhubl, Steven V Manoukian, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 3, 2015
Impact of anticoagulation regimen prior to revascularization in patients with non-ST-segment elevation acute coronary syndromes: The ACUITY trialTobias Geisler, Michal Droppa, Meinrad Gawaz, et al.
American Heart Journal|September 24, 2016
Rationale and design of Apo-I Event Reduction in Ischemic Syndromes I (AEGIS-I): A phase 2b, randomized, placebo-controlled, dose-ranging trial to investigate the safety and tolerability of CSL112, a reconstituted, infusible, human apoA-I, after acute myocardial infarctionC Michael Gibson, Serge Korjian, Pierluigi Tricoci, et al.
Journal of the American College of Cardiology|February 7, 2003
Safety of concomitant therapy with eptifibatide and enoxaparin in patients undergoing percutaneous coronary intervention: results of the Coronary Revascularization Using Integrilin and Single bolus Enoxaparin StudyDeepak L Bhatt, Benjamin I Lee, Peter J Casterella, et al.
Diabetes, Obesity & Metabolism|April 13, 2026
Semaglutide and Cardiovascular Outcomes According to Baseline Aspirin Use: Analyses of the SOUL and SELECT TrialsDirk Müller-Wieland, Darren K McGuire, A Michael Lincoff, et al.
JACC. Cardiovascular Interventions|April 23, 2011
Enhanced prediction of mortality after percutaneous coronary intervention by consideration of general and neurological indicatorsStephen G Ellis, Mehdi H Shishehbor, Samir R Kapadia, et al.
JAMA|June 24, 2023
Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant PatientsSteven E Nissen, Venu Menon, Stephen J Nicholls, et al.
JAMA|April 1, 2014
Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trialA Michael Lincoff, Jean-Claude Tardif, Gregory G Schwartz, et al.
Pageof 36

Showing results (241-250 of 353) with videos related to

Sort By:
Pageof 36
Circulation|December 23, 2009
Prognostic modeling of individual patient risk and mortality impact of ischemic and hemorrhagic complications: assessment from the Acute Catheterization and Urgent Intervention Triage Strategy trialStuart J Pocock, Roxana Mehran, Tim C Clayton, et al.
Journal of the American College of Cardiology|May 23, 2009
Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trialRamin Ebrahimi, Cornelius Dyke, Roxana Mehran, et al.
JACC. Cardiovascular Interventions|May 26, 2009
Influence of timing of clopidogrel treatment on the efficacy and safety of bivalirudin in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention: an analysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trialA Michael Lincoff, Steven R Steinhubl, Steven V Manoukian, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 3, 2015
Impact of anticoagulation regimen prior to revascularization in patients with non-ST-segment elevation acute coronary syndromes: The ACUITY trialTobias Geisler, Michal Droppa, Meinrad Gawaz, et al.
American Heart Journal|September 24, 2016
Rationale and design of Apo-I Event Reduction in Ischemic Syndromes I (AEGIS-I): A phase 2b, randomized, placebo-controlled, dose-ranging trial to investigate the safety and tolerability of CSL112, a reconstituted, infusible, human apoA-I, after acute myocardial infarctionC Michael Gibson, Serge Korjian, Pierluigi Tricoci, et al.
Journal of the American College of Cardiology|February 7, 2003
Safety of concomitant therapy with eptifibatide and enoxaparin in patients undergoing percutaneous coronary intervention: results of the Coronary Revascularization Using Integrilin and Single bolus Enoxaparin StudyDeepak L Bhatt, Benjamin I Lee, Peter J Casterella, et al.
Diabetes, Obesity & Metabolism|April 13, 2026
Semaglutide and Cardiovascular Outcomes According to Baseline Aspirin Use: Analyses of the SOUL and SELECT TrialsDirk Müller-Wieland, Darren K McGuire, A Michael Lincoff, et al.
JACC. Cardiovascular Interventions|April 23, 2011
Enhanced prediction of mortality after percutaneous coronary intervention by consideration of general and neurological indicatorsStephen G Ellis, Mehdi H Shishehbor, Samir R Kapadia, et al.
JAMA|June 24, 2023
Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant PatientsSteven E Nissen, Venu Menon, Stephen J Nicholls, et al.
JAMA|April 1, 2014
Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trialA Michael Lincoff, Jean-Claude Tardif, Gregory G Schwartz, et al.
Pageof 36